BOTOX® Cosmetic and Skin Health.

计划入组 34 人 · 首次发布于 2021 年 12 月 1 日

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

计划入组 125 人 · 首次发布于 2013 年 1 月 29 日

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

计划入组 40 人 · 首次发布于 2011 年 7 月 12 日

DaxibotulinumtoxinA(Botox, Botox Cosmetic, Daxxify, Dysport, Xeomin)

X-Synergy®

NanoLithium® NP03

Center For Clinical & Cosmetic Research

United States

Guangzhou Tingcai Cosmetic Co.,Ltd

China

China Ningbo Shangge Cosmetic Technology Corp.

China

BOTOX® Cosmetic Approved in China for Masseter Muscle Prominence

BOTOX® Cosmetic Receives FDA Approval for Platysma Bands

AbbVie Seeks FDA Approval for Novel Serotype E Botulinum Neurotoxin for Glabellar Lines